Why it was recalled
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Product description
Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
Lot numbers, UPCs & expiration codes
Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024.
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0526-2023
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Mar 23, 2023
- FDA report date
- Apr 12, 2023
- Quantity
- 32 Bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Preferred Pharmaceuticals, Inc.
Original FDA data
Every field from FDA enforcement report D-0526-2023, exactly as published.
Show all FDA fields
- City
- Anaheim
- State
- CA
- Status
- Ongoing
- Country
- United States
- Event ID
- 91952
- Address
- 1250 N Lakeview Ave Ste O
- Code information
- Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024.
- Postal code
- 92807-1801
- Report date
- Apr 12, 2023
- Product type
- Drugs
- Recall number
- D-0526-2023
- Classification
- Class II
- Recalling firm
- Preferred Pharmaceuticals, Inc.
- Product quantity
- 32 Bottles
- Reason for recall
- cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Mar 23, 2023
- Initial firm notification
- Letter
- Center classification date
- Apr 6, 2023